These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10649242

  • 21. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
    Younes M, Pathak M, Finnie D, Sifers RN, Liu Y, Schwartz MR.
    Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
    [Abstract] [Full Text] [Related]

  • 22. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer.
    Tamoto E, Tada M, Murakawa K, Takada M, Shindo G, Teramoto K, Matsunaga A, Komuro K, Kanai M, Kawakami A, Fujiwara Y, Kobayashi N, Shirata K, Nishimura N, Okushiba S, Kondo S, Hamada J, Yoshiki T, Moriuchi T, Katoh H.
    Clin Cancer Res; 2004 Jun 01; 10(11):3629-38. PubMed ID: 15173069
    [Abstract] [Full Text] [Related]

  • 23. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K, Komuta K, Hashimoto S, Matsuzaki S, Kanematsu T, Koji T.
    Clin Cancer Res; 2000 Sep 01; 6(9):3560-4. PubMed ID: 10999744
    [Abstract] [Full Text] [Related]

  • 24. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
    Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda S, Tachibana M, Ohno Y, Suzuki N, Inoue M, Soma G, Nagasue N.
    Anticancer Res; 2005 Sep 01; 25(1B):463-70. PubMed ID: 15816613
    [Abstract] [Full Text] [Related]

  • 25. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X, Watson DI, Jamieson GG.
    Chin Med J (Engl); 2007 Dec 20; 120(24):2268-70. PubMed ID: 18167216
    [Abstract] [Full Text] [Related]

  • 26. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC, Barnetson RS, Halliday GM.
    Br J Dermatol; 2004 Jul 20; 151(1):42-9. PubMed ID: 15270871
    [Abstract] [Full Text] [Related]

  • 27. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma.
    Hughes SJ, Nambu Y, Soldes OS, Hamstra D, Rehemtulla A, Iannettoni MD, Orringer MB, Beer DG.
    Cancer Res; 1997 Dec 15; 57(24):5571-8. PubMed ID: 9407969
    [Abstract] [Full Text] [Related]

  • 28. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
    Anticancer Res; 2007 Dec 15; 27(4A):1969-74. PubMed ID: 17649807
    [Abstract] [Full Text] [Related]

  • 29. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
    Kouvaraki M, Gorgoulis VG, Rassidakis GZ, Liodis P, Markopoulos C, Gogas J, Kittas C.
    Cancer; 2002 May 01; 94(9):2454-65. PubMed ID: 12015771
    [Abstract] [Full Text] [Related]

  • 30. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T, Hashimoto Y, Tanaka E, Kan T, Tsunoda S, Sato F, Higashiyama M, Okumura T, Shimada Y.
    Clin Cancer Res; 2006 Feb 15; 12(4):1308-16. PubMed ID: 16489088
    [Abstract] [Full Text] [Related]

  • 31. Fas and WAF1 expression in esophageal squamous cell carcinomas.
    Vlachos K, Siafakas N, Karameris A, Athanasas G, Theodoropoulos G, Parassi E, Peros G, Papadopoulos J, Hakim N.
    Int Surg; 2006 Feb 15; 91(6):320-5. PubMed ID: 17256429
    [Abstract] [Full Text] [Related]

  • 32. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance].
    Li SY, Yu B, An P, Zuo FY, Cai HY.
    Zhonghua Wai Ke Za Zhi; 2005 Sep 01; 43(17):1118-20. PubMed ID: 16194308
    [Abstract] [Full Text] [Related]

  • 33. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
    Cabanillas R, Rodrigo JP, Astudillo A, Domínguez F, Suárez C, Chiara MD.
    Cancer; 2007 May 01; 109(9):1791-8. PubMed ID: 17380529
    [Abstract] [Full Text] [Related]

  • 34. Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: diffuse down-regulation is associated with immune evasion and brain metastasis.
    Ohshima K, Hamasaki M, Makimoto Y, Yoneda S, Fujii A, Takamatsu Y, Nakashima M, Watanabe T, Kawahara K, Kikuchi M, Shirakusa T.
    Int J Oncol; 2003 Oct 01; 23(4):965-73. PubMed ID: 12963975
    [Abstract] [Full Text] [Related]

  • 35. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.
    Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H.
    Gynecol Oncol; 2005 Jun 01; 97(3):772-9. PubMed ID: 15943986
    [Abstract] [Full Text] [Related]

  • 36. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Sakurai T, Owaki T, Aikou T.
    J Surg Oncol; 2008 Apr 01; 97(5):433-8. PubMed ID: 18176915
    [Abstract] [Full Text] [Related]

  • 37. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence.
    Belluco C, Esposito G, Bertorelle R, Alaggio R, Giacomelli L, Bianchi LC, Nitti D, Lise M.
    Eur J Surg Oncol; 2002 Mar 01; 28(2):120-5. PubMed ID: 11884046
    [Abstract] [Full Text] [Related]

  • 38. Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.
    Yoshinaga K, Yamashita K, Mimori K, Tanaka F, Inoue H, Mori M.
    Ann Surg Oncol; 2008 Jan 01; 15(1):96-103. PubMed ID: 17909904
    [Abstract] [Full Text] [Related]

  • 39. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J, Bennett MW, O'Sullivan GC, Roche D, Kelly J, Collins JK, Shanahan F.
    J Pathol; 1998 Nov 01; 186(3):240-6. PubMed ID: 10211111
    [Abstract] [Full Text] [Related]

  • 40. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, Nosho K, Imsumran A, Fujita M, Hosokawa M, Hinoda Y, Imai K.
    Carcinogenesis; 2004 Dec 01; 25(12):2353-60. PubMed ID: 15333466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.